Litcius/Paper detail

Poziotinib for EGFR exon 20-mutant NSCLC: Clinical efficacy, resistance mechanisms, and impact of insertion location on drug sensitivity

Yasir Y. Elamin, Jacqulyne Robichaux, Brett W. Carter, Mehmet Altan, Hai T. Tran, Don L. Gibbons, Simon Heeke, Frank V. Fossella, Vincent K. Lam, Xiuning Le, Marcelo V. Negrão, Monique B. Nilsson, Anisha B. Patel, R. S. K. Vijayan, Jason B. Cross, Jianjun Zhang, Lauren A. Byers, Charles Lu, Tina Cascone, Lei Feng, Rajyalakshmi Luthra, F. Anthony San Lucas, Geeta Mantha, Mark Routbort, George R. Blumenschein, Anne S. Tsao, John V. Heymach

2022Cancer Cell106 citationsDOIOpen Access PDF

Topics & Concepts

T790MExonPoint mutationMutantCancer researchMutationDrug resistanceLung cancerBiologynon-small cell lung cancer (NSCLC)MedicineCancerEpidermal growth factor receptorOncologyInternal medicineGeneGeneticsGefitinibA549 cellLung Cancer Treatments and MutationsPI3K/AKT/mTOR signaling in cancerCancer Genomics and Diagnostics